Yang Luo

1.4k total citations
40 papers, 1.1k citations indexed

About

Yang Luo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yang Luo has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Yang Luo's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Yang Luo is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Yang Luo collaborates with scholars based in China, United States and Germany. Yang Luo's co-authors include Ming Zhong, Minhao Yu, Shao‐Lan Qin, Yifei Mu, Yizhou Huang, Jonathan A. Epstein, Patricia Ruíz, Wolfgang Wurst, Wenting Zhu and Charles S. Abrams and has published in prestigious journals such as Nature Medicine, Biochemical and Biophysical Research Communications and Chemistry - A European Journal.

In The Last Decade

Yang Luo

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Luo China 17 748 291 274 112 95 40 1.1k
Yee Sun Tan United States 11 523 0.7× 432 1.5× 222 0.8× 201 1.8× 82 0.9× 16 981
Mitchell B. Diccianni United States 24 961 1.3× 407 1.4× 435 1.6× 169 1.5× 128 1.3× 40 1.5k
Huahong Xie China 22 812 1.1× 441 1.5× 249 0.9× 69 0.6× 79 0.8× 43 1.1k
Donna P. Frazier United States 17 562 0.8× 156 0.5× 294 1.1× 58 0.5× 53 0.6× 19 854
Yanhui Yin China 16 426 0.6× 176 0.6× 207 0.8× 238 2.1× 48 0.5× 27 725
Pu Zhang China 13 450 0.6× 112 0.4× 199 0.7× 99 0.9× 47 0.5× 19 876
Raffaela Santoro Italy 18 437 0.6× 215 0.7× 363 1.3× 90 0.8× 27 0.3× 28 874
Chian‐Feng Chen Taiwan 18 533 0.7× 240 0.8× 150 0.5× 56 0.5× 54 0.6× 32 830
Tewfik Hamidi France 14 622 0.8× 164 0.6× 204 0.7× 105 0.9× 65 0.7× 18 889
Henrick Horita United States 12 539 0.7× 158 0.5× 146 0.5× 238 2.1× 57 0.6× 18 859

Countries citing papers authored by Yang Luo

Since Specialization
Citations

This map shows the geographic impact of Yang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Luo more than expected).

Fields of papers citing papers by Yang Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Luo. The network helps show where Yang Luo may publish in the future.

Co-authorship network of co-authors of Yang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Luo. A scholar is included among the top collaborators of Yang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Luo. Yang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Yuanyuan, et al.. (2025). MiR-147b-3p promotes osteogenesis by targeting NDUFA4 and PI3K/AKT pathway. Journal of Orthopaedic Surgery and Research. 20(1). 235–235. 1 indexed citations
2.
Zeng, Zhiyang, Yang Luo, Zhengwei Li, et al.. (2025). Downregulation of METTL3 enhances TRADD-mediated apoptosis in inflammatory bowel disease. Science China Life Sciences. 68(7). 2010–2027. 1 indexed citations
3.
Zhang, Ying, Qingdong Zhang, Li Quan, et al.. (2025). Mechanical stress facilitates calcium influx and growth of alveolar epithelial cells via activation of the BDKRB1/Ca2+/CaMKII/MEK1/ERK axis. Respiratory Research. 26(1). 168–168. 1 indexed citations
5.
Yu, Minhao, Yuan Shi, Yang Luo, et al.. (2024). Targeting AQP9 enhanced the anti-TNF therapy response in Crohn's disease by inhibiting LPA-hippo pathway. Pharmacological Research. 203. 107172–107172. 3 indexed citations
6.
Lü, Can, et al.. (2022). Identification of CXCL10 and CXCL11 as the candidate genes involving the development of colitis-associated colorectal cancer. Frontiers in Genetics. 13. 945414–945414. 11 indexed citations
7.
Qin, Shao‐Lan, Yang Luo, Yizhou Huang, et al.. (2021). AIM2 Inhibits BRAF-Mutant Colorectal Cancer Growth in a Caspase-1-Dependent Manner. Frontiers in Cell and Developmental Biology. 9. 588278–588278. 9 indexed citations
8.
11.
Luo, Yang, Minhao Yu, Yong Zhou, et al.. (2020). Rab27A promotes cellular apoptosis and ROS production by regulating the miRNA‐124‐3p/STAT3/RelA signalling pathway in ulcerative colitis. Journal of Cellular and Molecular Medicine. 24(19). 11330–11342. 27 indexed citations
12.
Cui, Ran, Minhao Yu, Jianjun Chen, et al.. (2019). Monopolar Electrosurgical Scissors Versus Harmonic Scalpel in Robotic Anterior Resection of Rectal Cancer: A Retrospective Cohort Study. Journal of Laparoendoscopic & Advanced Surgical Techniques. 29(7). 880–885. 2 indexed citations
13.
Yu, Minhao, Ran Cui, Yizhou Huang, et al.. (2019). Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway. EBioMedicine. 48. 264–276. 34 indexed citations
14.
Qin, Shao‐Lan, Yong Zhou, Jianjun Chen, et al.. (2018). Low levels of TSC22 enhance tumorigenesis by inducing cell proliferation in colorectal cancer. Biochemical and Biophysical Research Communications. 497(4). 1062–1067. 3 indexed citations
15.
Luo, Yang, Jianjun Chen, Qiang Lv, et al.. (2018). Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/β-catenin signaling pathway. Cancer Letters. 440-441. 11–22. 115 indexed citations
16.
Luo, Yang, Shao‐Lan Qin, Yifei Mu, et al.. (2018). Increased epoxyeicosatrienoic acids may be part of a protective mechanism in human ulcerative colitis, with increased CYP2J2 and reduced soluble epoxide hydrolase expression. Prostaglandins & Other Lipid Mediators. 136. 9–14. 10 indexed citations
17.
Chen, Jianjun, Yang Luo, Yong Zhou, et al.. (2018). Promotion of Tumor Growth by ADAMTS4 in Colorectal Cancer: Focused on Macrophages. Cellular Physiology and Biochemistry. 46(4). 1693–1703. 22 indexed citations
18.
Zhang, Yan, Yang Luo, Shao‐Lan Qin, et al.. (2016). The clinical impact of ICOS signal in colorectal cancer patients. OncoImmunology. 5(5). e1141857–e1141857. 68 indexed citations
19.
Luo, Yang, et al.. (2015). Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer. Biomedicine & Pharmacotherapy. 73. 135–139. 17 indexed citations
20.
Luo, Yang, Shao‐Lan Qin, Minhao Yu, et al.. (2015). Prognostic value of regulator of G-protein signaling 6 in colorectal cancer. Biomedicine & Pharmacotherapy. 76. 147–152. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026